Siga Technologies (SIGA) EBT Margin Growth (1y) (2011 - 2025)
Analysis
Siga Technologies (SIGA) EBT Margin Growth (1y) (2011 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | -68.00 |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | 1,510.00 |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | -3,574.00 |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | -261.00 |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | -2,512.00 |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | -504.00 |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | - |
| 8 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | -101.00 |
| 9 | United Therapeutics | 20.81 Bn | 18.15 Bn | 683.80 Mn | -356.00 |
| 10 | Siga Technologies | 235.60 Mn | 80.63 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -33,763.00 |
| Jun 30, 2025 | 4,728.00 |
| Mar 31, 2025 | -6,008.00 |
| Dec 31, 2024 | -782.00 |
| Sep 30, 2024 | 2,332.00 |
| Jun 30, 2024 | 6,965.00 |
| Mar 31, 2024 | 6,661.00 |
| Dec 31, 2023 | 8,965.00 |
| Sep 30, 2023 | -6,434.00 |
| Jun 30, 2023 | -7,781.00 |
| Mar 31, 2023 | -453.00 |
| Dec 31, 2022 | -9,130.00 |
| Sep 30, 2022 | 14,194.00 |
| Jun 30, 2022 | 1,375.00 |
| Mar 31, 2022 | 1,161.00 |
| Dec 31, 2021 | 1,180.00 |
| Sep 30, 2021 | -15,372.00 |
| Jun 30, 2021 | -6,203.00 |
| Mar 31, 2021 | 42,108.00 |
| Dec 31, 2020 | 22,114.00 |